Company / Interest Expense
Kura Oncology, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$1.5M
FY2023
5-year range
$229.0K / $1.5M
FY2019-FY2023
Trend
+576.4%
vs FY2022
Sector context
#37 of 44
Health Care
What the data says
Interest Expense changed +576% YoY in FY2023, a notable deviation from the 7-year average annual change of +75%.
Based on SEC 10-K filings.
$2M in FY2023 with a 5-year CAGR of +9.8%.
Increased from $414,000 to $2M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +38.9%
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 44This company $1.5M Sector average $291.0M
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.8%, indicating consistent growth.
- In FY2023, interest expense increased 576.4% year-over-year.
- Ranks #37 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.5M | +576.4% |
| FY2022 | $229.0K | -44.7% |
| FY2021 | $414.0K | -28.4% |
| FY2020 | $578.0K | -0.3% |
| FY2019 | $580.0K | -40.2% |
| FY2018 | $970.0K | +9.2% |
| FY2017 | $888.0K | +53.9% |
| FY2016 | $577.0K | +1273.8% |
As of FY2023 · SEC 10-K · Updated Mar 28, 2026